Overview A Safety and Tolerability Study of ABT-089 in Children With Attention-Deficit/Hyperactivity Disorder (ADHD) Status: Terminated Trial end date: 1969-12-31 Target enrollment: Participant gender: Summary The objective of this study is to evaluate the long-term safety and tolerability of ABT-089 in children with ADHD. Phase: Phase 2 Details Lead Sponsor: Abbott